A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis

Clinical trial NCT05155085 · TERMINATED

Trial details

NCT number: NCT05155085
Sponsor: Allakos Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2022-06-27
Primary completion: 2023-12-18
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.